Indiana University researchers continue to turn ideas and innovations from their labs into inventions, patents, new technologies and startups.
The IU Innovation and Commercialization Office, whose mission is to transfer IU innovations from lab to market for public benefit and global impact, reported that IU faculty, staff and student researchers disclosed 144 inventions to the office during the fiscal year beginning July 1, 2022, and ending June 30, 2023. The researchers represent IU’s Bloomington and Indianapolis campuses and the IU School of Medicine, the nation’s largest medical school with nine statewide campuses.
“We have seen exciting innovations disclosed to our office this past year, and we are committed to continuing to support IU researchers and bringing their innovations to market,” said Lakshmi Sastry-Dent, director of technology commercialization at IU ICO.
Other fiscal year 2023 highlights include:
- 317 patent applications were filed with the U.S. Patent and Trademark Office and foreign patent organizations.
- 98 U.S. and international patents were issued for innovations such as a wireless sensor network, a treatment for breast cancer, a method for treating salt and water balance diseases, and more.
- 22 license agreements and 39 other agreements were executed.
- 4 startups were formed.
Watch a video below on research led by IUPUI School of Science Professor Bonnie Blazer-Yost. Blazer-Yost received a patent from the U.S. Patent and Trademark Office for a method utilizing SGK1 inhibitors that reduce sodium reabsorption in the blood, thus reducing the development of diseases related to salt and water balance, particularly for hydrocephalus and hypertension.
Bri Heron, technology marketing manager at Indiana University’s Innovation and Commercialization Office, contributed this story.